Pacific Biosciences Of California (PACB) Selling, General & Administrative (2010 - 2026)
Pacific Biosciences Of California (PACB) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | 33.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.39 Mn |
| Mar 31, 2026 | 31.15 Mn |
| Dec 31, 2025 | 34.05 Mn |
| Sep 30, 2025 | 31.10 Mn |
| Jun 30, 2025 | 36.18 Mn |
| Mar 31, 2025 | 40.17 Mn |
| Dec 31, 2024 | 41.64 Mn |
| Sep 30, 2024 | 43.75 Mn |
| Jun 30, 2024 | 45.88 Mn |
| Mar 31, 2024 | 43.75 Mn |
| Dec 31, 2023 | 46.00 Mn |
| Sep 30, 2023 | 43.43 Mn |
| Jun 30, 2023 | 40.57 Mn |
| Mar 31, 2023 | 39.82 Mn |
| Dec 31, 2022 | 45.00 Mn |
| Sep 30, 2022 | 36.80 Mn |
| Jun 30, 2022 | 39.25 Mn |
| Mar 31, 2022 | 39.80 Mn |
| Dec 31, 2021 | 37.32 Mn |
| Jun 30, 2021 | 29.06 Mn |